These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36781357)

  • 41. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study.
    Wiedmann M; Caca K; Berr F; Schiefke I; Tannapfel A; Wittekind C; Mössner J; Hauss J; Witzigmann H
    Cancer; 2003 Jun; 97(11):2783-90. PubMed ID: 12767091
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outcome after liver resection for primary and recurrent intrahepatic cholangiocarcinoma.
    Nickkholgh A; Ghamarnejad O; Khajeh E; Tinoush P; Bruckner T; Kulu Y; Mieth M; Goeppert B; Roessler S; Weiss KH; Hoffmann K; Büchler MW; Mehrabi A
    BJS Open; 2019 Dec; 3(6):793-801. PubMed ID: 31832586
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection.
    Witzigmann H; Berr F; Ringel U; Caca K; Uhlmann D; Schoppmeyer K; Tannapfel A; Wittekind C; Mossner J; Hauss J; Wiedmann M
    Ann Surg; 2006 Aug; 244(2):230-9. PubMed ID: 16858185
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gemcitabine and Cisplatin as Neo-Adjuvant for Cholangiocarcinoma Patients Prior to Liver Transplantation: Case-Series.
    Abdelrahim M; Al-Rawi H; Esmail A; Xu J; Umoru G; Ibnshamsah F; Abudayyeh A; Victor D; Saharia A; McMillan R; Al Najjar E; Bugazia D; Al-Rawi M; Ghobrial RM
    Curr Oncol; 2022 May; 29(5):3585-3594. PubMed ID: 35621680
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radioembolization Plus Chemotherapy for First-line Treatment of Locally Advanced Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial.
    Edeline J; Touchefeu Y; Guiu B; Farge O; Tougeron D; Baumgaertner I; Ayav A; Campillo-Gimenez B; Beuzit L; Pracht M; Lièvre A; Le Sourd S; Boudjema K; Rolland Y; Boucher E; Garin E
    JAMA Oncol; 2020 Jan; 6(1):51-59. PubMed ID: 31670746
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Defining the Benefit of Adjuvant Therapy Following Resection for Intrahepatic Cholangiocarcinoma.
    Sur MD; In H; Sharpe SM; Baker MS; Weichselbaum RR; Talamonti MS; Posner MC
    Ann Surg Oncol; 2015 Jul; 22(7):2209-17. PubMed ID: 25476031
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fluoropyrimidines plus cisplatin versus gemcitabine/gemcitabine plus cisplatin in locally advanced and metastatic biliary tract carcinoma - a retrospective study.
    Croitoru A; Gramaticu I; Dinu I; Gheorghe L; Alexandrescu S; Buica F; Luca I; Becheanu G; Herlea V; Simionov I; Hrehoret D; Lupescu I; Popescu I; Diculescu M
    J Gastrointestin Liver Dis; 2012 Sep; 21(3):277-84. PubMed ID: 23012669
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [A long term survival case of hilar cholangiocarcinoma with multiple metastases treated with chemotherapy and operation].
    Shirasaki K; Morikawa T; Otsuka H; Katayose Y; Unno M
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1530-2. PubMed ID: 25731242
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surgical Resection for Recurrent Intrahepatic Cholangiocarcinoma.
    Bartsch F; Paschold M; Baumgart J; Hoppe-Lotichius M; Heinrich S; Lang H
    World J Surg; 2019 Apr; 43(4):1105-1116. PubMed ID: 30523392
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A case of curative resection after downsizing chemotherapy in initially unresectable locally advanced intrahepatic cholangiocarcinoma].
    Aoki Y; Suzuki T; Kato A; Shimizu H; Ohtsuka M; Yoshitomi H; Furukawa K; Takayashiki T; Kuboki S; Takano S; Okamura D; Suzuki D; Sakai N; Kagawa S; Miyazaki M
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1509-11. PubMed ID: 25731235
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
    Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
    Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outcomes for Patients with Recurrent Intrahepatic Cholangiocarcinoma After Surgery.
    Park HM; Yun SP; Lee EC; Lee SD; Han SS; Kim SH; Park SJ
    Ann Surg Oncol; 2016 Dec; 23(13):4392-4400. PubMed ID: 27581609
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic implications of hepatitis B virus infection in intrahepatic cholangiocarcinoma treated with first-line gemcitabine plus cisplatin.
    Chae H; Cho H; Yoo C; Kim KP; Jeong JH; Chang HM; Kang J; Lee HC; Lim YS; Kim KM; Shim JH; Lee SS; Park DH; Song TJ; Hwang S; Song GW; Moon DB; Lee YJ; Lee JH; Ryoo BY
    Int J Biol Markers; 2018 Nov; 33(4):432-438. PubMed ID: 29874985
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combination chemotherapy with gemcitabine and cisplatin as first-line treatment for immunohistochemically proven cholangiocarcinoma.
    Lee GW; Kang JH; Kim HG; Lee JS; Lee JS; Jang JS
    Am J Clin Oncol; 2006 Apr; 29(2):127-31. PubMed ID: 16601429
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A case of intrahepatic cholangiocarcinoma with peritoneal dissemination treated successfully with surgical resection and adjuvant chemotherapy].
    Shiozaki S; Satoh D; Matsukawa H; Yamaguchi K; Takahashi K; Mimura N; Taguchi K; Araki H; Toshima T; Kato T; Miyake S; Miyoshi H; Yoshida K; Choda Y; Tokumoto N; Kanazawa T; Harano M; Ojima Y; Idani H; Okajima M; Ninomiya M
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2089-91. PubMed ID: 25731432
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Impact of Surgical Margin Status on Long-Term Outcome After Resection for Intrahepatic Cholangiocarcinoma.
    Spolverato G; Yakoob MY; Kim Y; Alexandrescu S; Marques HP; Lamelas J; Aldrighetti L; Gamblin TC; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Marsh JW; Pawlik TM
    Ann Surg Oncol; 2015 Nov; 22(12):4020-8. PubMed ID: 25762481
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High platelet-to-lymphocyte ratio is associated with poor prognosis in patients with unresectable intrahepatic cholangiocarcinoma receiving gemcitabine plus cisplatin.
    Huh G; Ryu JK; Chun JW; Kim JS; Park N; Cho IR; Paik WH; Lee SH; Kim YT
    BMC Cancer; 2020 Sep; 20(1):907. PubMed ID: 32967632
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Locally Advanced Intrahepatic Cholangiocarcinoma: Complete Pathologic Response to Neoadjuvant Chemotherapy Followed by Left Hepatic Trisectionectomy and Caudate Lobectomy.
    Tran TB; Bal CK; Schaberg K; Longacre TA; Chatrath BS; Poultsides GA
    Dig Dis Sci; 2015 Nov; 60(11):3226-9. PubMed ID: 25824976
    [No Abstract]   [Full Text] [Related]  

  • 59. Very Early Recurrence After Liver Resection for Intrahepatic Cholangiocarcinoma: Considering Alternative Treatment Approaches.
    Tsilimigras DI; Sahara K; Wu L; Moris D; Bagante F; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Soubrane O; Koerkamp BG; Moro A; Sasaki K; Aucejo F; Zhang XF; Matsuyama R; Endo I; Pawlik TM
    JAMA Surg; 2020 Sep; 155(9):823-831. PubMed ID: 32639548
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Survival analysis of intrahepatic cholangiocarcinoma after resection.
    Cho SY; Park SJ; Kim SH; Han SS; Kim YK; Lee KW; Lee SA; Hong EK; Lee WJ; Woo SM
    Ann Surg Oncol; 2010 Jul; 17(7):1823-30. PubMed ID: 20165987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.